ENDEP Drug Patent Profile
When do Endep patents expire, and what generic alternatives are available?
Endep is a drug marketed by Roche and is included in three NDAs.
The generic ingredient in ENDEP is amitriptyline hydrochloride. There is one drug master file entry for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Endep
A generic version of ENDEP was approved as amitriptyline hydrochloride by SUN PHARM INDS INC on July 14th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ENDEP?
- What are the global sales for ENDEP?
- What is Average Wholesale Price for ENDEP?
Summary for ENDEP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 120 |
| Patent Applications: | 3,945 |
| DailyMed Link: | ENDEP at DailyMed |
US Patents and Regulatory Information for ENDEP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | ENDEP | amitriptyline hydrochloride | CONCENTRATE;ORAL | 085749-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | ENDEP | amitriptyline hydrochloride | TABLET;ORAL | 085303-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | ENDEP | amitriptyline hydrochloride | TABLET;ORAL | 083639-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
